Miura, Kazutoyo http://orcid.org/0000-0003-4455-2432
Takashima, Eizo http://orcid.org/0000-0001-9070-8499
Pham, Thao P.
Deng, Bingbing
Zhou, Luwen
Huang, Wei-Chiao
Diouf, Ababacar
Gebremicale, Yonas T.
Tachibana, Mayumi
Ishino, Tomoko
Richter King, C.
Lovell, Jonathan F. http://orcid.org/0000-0002-9052-884X
Long, Carole A.
Tsuboi, Takafumi http://orcid.org/0000-0002-7415-1325
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
PATH
MEXT | Japan Society for the Promotion of Science (JP20H03481, JP21H02724, JP20H03480, JP20H03480)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI148557, R01AI148557, R01AI148557)
Global Health Innovative Technology (GHIT) Fund
PATH’s Malaria Vaccine Initiative
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 30 June 2021
Accepted: 30 November 2021
First Online: 13 January 2022
Competing interests
: W.H. and J.F.L. hold interest in POP Biotechnologies. The other authors declare no competing interests.